H. Pylori (Helicobacter Pylori) Test Market Research Report - Global Forecast till 2027

Global H. Pylori (Helicobacter Pylori) Test Market Research Report: By Test Type (Non-Endoscopic, Endoscopic), By Technology (Immunoassays, Point-of-Care (POC), Molecular Diagnostics) and By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others) – Forecast to 2027

ID: MRFR/HC/7025-HCR | February, 2021 | Region : Global

Market Forecast

H. Pylori (Helicobacter Pylori) Test Market is expected to hold a value of USD 2,924.2 Million by 2025 at a CAGR of 5.2%.


Helicobacter pylori tests are used to detect an H. pylori infection in the stomach and upper part of the small intestine (duodenum). There has been a high burden of helicobacter pylori across the world. H. pylori infection is one of the world's most common an. In 2019, the prevalence of H. pylori infection reported a wide range from 18.9% in Switzerland up to 87.7% in Nigeria.


Market Influencer


In 2015, the worldwide prevalence of H. pylori was 4.4 billion individuals, and currently, it ranges between 85% and 95% in developing countries and between 30 and 50% (out of total population) in developed countries. Thus, the worldwide prevalence of H. pylori would influence the market growth during the study period. Global rising incidence of H. pylori infections accompanied by dyspepsia, availability of diagnostic tests, the presence of contaminated water or food, poor sanitation, high dense population, and poor personal hygiene are the factors expected to support the market growth over the assessment period.


Market Drivers



  • Worldwide surging target patient population



  • The rising burden of H. pylori and associated dyspepsia



  • Growing awareness about H. pylori diagnosis among individuals: In October 2019, the Healthy Stomach Initiative (HSI) taken the initiative to raise awareness of and boost research about gastric cancer and associated H. pylori infection. About 90% of gastric cancer cases are related to H. pylori in the European Union (EU) every year. This is propelling the demand for the H. pylori diagnosis thereby nurturing the market growth.



  • Improved cost-effectiveness of H. pylori diagnosis: Serology testing and stool antigen testing are more cost-effective than the currently most recommended C-urea breath test. Moreover, the decision analysis model indicates that the H. pylori test and treat strategy is the most cost-effective method for managing dyspepsia and currently costing USD 134/patient/year compared with USD 240 per patient per year for prompt endoscopy in the UK.



  • Globally increasing geriatric population


Market Restraint



  • The low number of diagnosis tests opted by patients


Segmentation


By Test Type



  • Non-Endoscopic: This segment has been further categorized as stool/fecal antigen test (SAT), urea breath test (UBT), and serology/antibody/blood test. The non-endoscopic segment is expected to dominate the market during the forecast period as SAT and UBT are recommended for the diagnosis of H. pylori infection and the evaluation of the effectiveness of treatment.



  • Endoscopic: This segment has been divided into culture, histology, rapid urease/Campylobacter-like organism (CLO) test, and polymerase chain reaction (PCR).


By Technology



  • Immunoassays: The immunoassays segment spearheaded the market in 2018 due to the higher adoption of enzyme immunoassays for the detection of antibodies.



  • Point-of-Care (POC): Non-invasive H. pylori diagnostic tests are available for point-of-care use in primary care and include IgG serology, monoclonal stool antigen, and C-urea breath test.



  • Molecular Diagnostics: Molecular diagnostic methods such as polymerase chain reaction provides marginal improvements when done on biopsy material and can precisely identify H. pylori in areas outside the stomach where cultures usually fail.


By End-User



  • Hospitals and Clinics: A gradual rise in the number of government and private hospitals in emerging nations such as China and India, along with an increase in the number of pylori tests performed in hospitals and clinics, are expected to support the dominance of this segment.



  • Diagnostics Laboratories: Expected to register the fastest CAGR during the forecast period due to the rising number of healthcare facilities and medical laboratories around the globe.



  • Others: This segment comprises ambulatory surgery centers, etc.


By Region



  • Americas: The presence of diagnostic companies such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporated, Cardinal Health, and Abbott Laboratories in the US facilitates early product (test kits, reagents/assays, etc.) launches of along with prompt product supply in the market, thereby supporting the dominance of Americas



  • Europe: Europe is expected to be the second-largest market, following the Americas in terms of value during the forecast period. Resistance to antibiotics commonly used to treat Helicobacter pylori infection has increased manifold in the region in the past 20 years. This may reflect overconsumption of antibiotics and lack of support for programs aimed at curbing resistance in the near future.



  • Asia-Pacific: Asia-Pacific is projected to represent lucrative market growth owing to the presence of target population base and poor sanitation conditions in the region coupled with the rising burden of the H. pylori infection



  • Middle East & Africa: The market in this region will register the modest market growth. For instance, in 2018, the prevalence of H. pylori in Oman and Saudi Arabia was 49.1% and 65.9%, respectively. This prevalence is likely to contribute to regional market growth.


Key Players



  • Thermo Fisher Scientific Inc. (US)

  • Bio-Rad Laboratories, Inc. (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Quest Diagnostics Incorporated (US)

  • Meridian Bioscience (US)

  • CorisBioconcept SPRL (Belgium)

  • Cardinal Health (US)

  • QIAGEN (Germany)

  • Abbott Laboratories (US)

  • Biohit Oyj (Finland)

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global H. Pylori Test Market, by Test Type

1.1.2. Global H. Pylori Test Market, by Technology

1.1.3. Global H. Pylori Test Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL H. PYLORI TEST MARKET, BY TEST TYPE

6.1. Overview

6.2. Non-Endoscopic

6.2.1. Stool/Fecal Antigen Test (SAT)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Urea Breath Test (UBT)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Serology/Antibody/Blood Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Endoscopic

6.3.1. Culture

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Histology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Rapid Urease/Campylobacter-Like Organism (CLO) Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Polymerase Chain Reaction (PCR)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL H. PYLORI TEST MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Immunoassays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Point-of-Care (POC)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Molecular Diagnostics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL H. PYLORI TEST MARKET, BY END USER

8.1. Overview

8.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Diagnostics Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL H. PYLORI TEST MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategies in the H. Pylori Test Market

10.4. Competitive Benchmarking

10.5. The Leading Players in terms of Number of Developments in the H. Pylori Test Market

10.6. Key Developments & Growth Strategies

10.7. Major Market Players Financial Matrix & Market Ratio

11. COMPANY PROFILES

11.1. Thermo Fisher Scientific Inc.

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Bio-Rad Laboratories, Inc.

11.2.1. Company Overview

11.2.2. Products/Services Offered

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. F. Hoffmann-La Roche Ltd

11.3.1. Company Overview

11.3.2. Products/Services Offered

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Quest Diagnostics Incorporated

11.4.1. Company Overview

11.4.2. Products/Services Offered

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Meridian Bioscience

11.5.1. Company Overview

11.5.2. Products/Services Offered

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. CorisBioconcept SPRL

11.6.1. Company Overview

11.6.2. Products/Services Offered

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Cardinal Health

11.7.1. Company Overview

11.7.2. Products/Services Offered

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. QIAGEN

11.8.1. Company Overview

11.8.2. Products/Services Offered

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Abbott Laboratories

11.9.1. Company Overview

11.9.2. Products/Services Offered

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Biohit Oyj

11.10.1. Company Overview

11.10.2. Products/Services Offered

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL H. PYLORI TEST MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL H. PYLORI TEST MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL H. PYLORI TEST MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 US: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 12 US: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 13 CANADA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 15 CANADA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET, BY END USER, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL H. PYLORI TEST MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL H. PYLORI TEST MARKET

FIGURE 4 GLOBAL H. PYLORI TEST MARKET SHARE, BY TEST TYPE, 2020 (%)

FIGURE 5 GLOBAL H. PYLORI TEST MARKET SHARE, BY TECHNOLOGY, 2020 (%)

FIGURE 6 GLOBAL H. PYLORI TEST MARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL H. PYLORI TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: H. PYLORI TEST MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: H. PYLORI TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: H. PYLORI TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL H. PYLORI TEST MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 THERMO FISHER SCIENTIFIC INC.: KEY FINANCIALS

FIGURE 16 THERMO FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE

FIGURE 17 THERMO FISHER SCIENTIFIC INC.: REGIONAL REVENUE

FIGURE 18 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS

FIGURE 19 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE

FIGURE 20 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE

FIGURE 21 F. HOFFMANN-LA ROCHE LTD: KEY FINANCIALS

FIGURE 22 F. HOFFMANN-LA ROCHE LTD: SEGMENTAL REVENUE

FIGURE 23 F. HOFFMANN-LA ROCHE LTD: REGIONAL REVENUE

FIGURE 24 QUEST DIAGNOSTICS INCORPORATED: KEY FINANCIALS

FIGURE 25 QUEST DIAGNOSTICS INCORPORATED: SEGMENTAL REVENUE

FIGURE 26 QUEST DIAGNOSTICS INCORPORATED: REGIONAL REVENUE

FIGURE 27 MERIDIAN BIOSCIENCE: KEY FINANCIALS

FIGURE 28 MERIDIAN BIOSCIENCE: SEGMENTAL REVENUE

FIGURE 29 MERIDIAN BIOSCIENCE: REGIONAL REVENUE

FIGURE 30 CORISBIOCONCEPT SPRL: KEY FINANCIALS

FIGURE 31 CORISBIOCONCEPT SPRL: SEGMENTAL REVENUE

FIGURE 32 CORISBIOCONCEPT SPRL: REGIONAL REVENUE

FIGURE 33 CARDINAL HEALTH: KEY FINANCIALS

FIGURE 34 CARDINAL HEALTH: SEGMENTAL REVENUE

FIGURE 35 CARDINAL HEALTH: REGIONAL REVENUE

FIGURE 36 QIAGEN: KEY FINANCIALS

FIGURE 37 QIAGEN: SEGMENTAL REVENUE

FIGURE 38 QIAGEN: REGIONAL REVENUE

FIGURE 39 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 40 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 41 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 42 BIOHIT OYJ: KEY FINANCIALS

FIGURE 43 BIOHIT OYJ: SEGMENTAL REVENUE

FIGURE 44 BIOHIT OYJ: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Helicobacter Pylori Test Market